Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:771-773
doi: 10.1161/CIRCULATIONAHA.105.605600
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feldman, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feldman, T.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Valve Diseases
Related Collections
Right arrow Catheter-based coronary and valvular interventions: other

(Circulation. 2006;113:771-773.)
© 2006 American Heart Association, Inc.


Editorial

Percutaneous Valve Repair and Replacement

Challenges Encountered, Challenges Met, Challenges Ahead

Ted Feldman, MD

From the Cardiology Division, Evanston Hospital, Evanston, Ill.

Correspondence to Ted Feldman, MD, Cardiology Division, Burch 300, Evanston Hospital, 2650 Ridge Ave, Evanston, IL 60201. E-mail tfeldman@enh.org


Key Words: Editorials • mitral repair • valve replacement • valves


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
This issue of Circulation contains reports on the acute results of 2 approaches for percutaneous heart valve treatment.1,2 The introduction of nonsurgical, catheter-based approaches to the management of valvular heart disease is in a phase of rapid development. These 2 reports highlight both challenges and successes in phase I experience with these innovative therapies.

Articles pp 842 and 851

Percutaneous valve therapy developed initially with aortic valve replacement, described by Andersen et al3 in 1992 in a swine model. These investigators fabricated a stent-mounted bioprosthetic valve and demonstrated that percutaneous implantation is feasible. Bonhoeffer et al4 reported the use of a stent-mounted bioprosthesis for pulmonic valve replacement in 2000. This achievement clearly marked the beginning of the era of percutaneous valve replacement therapy in patients. Pulmonic valve replacement with this percutaneous approach has been remarkably successful. To date, >100 patients have been treated, with only a single procedure-related mortality and good results in a population of pediatric patients with congenital heart disease who otherwise would face third or fourth open heart procedures. Percutaneous aortic valve replacement with a stent-mounted bioprosthetic valve device was initially reported by Cribier et al5,6 in 2002, with a growing experience since then.


*    Challenges Encountered
 
Numerous technical and clinical challenges have been encountered during phase I procedures for percutaneous heart valve therapy. The patient population for aortic valve replacement has been a group of patients considered high risk for surgery or nonsurgical candidates with numerous comorbid conditions. These patients have come to the cardiac catheterization laboratory with hypotension . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
Y. Suzuki, A. C. Yeung, and F. Ikeno
The Pre-Clinical Animal Model in the Translational Research of Interventional Cardiology
J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 373 - 383.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. K. Rosengart, T. Feldman, M. A. Borger, T. A. Vassiliades Jr, A. M. Gillinov, K. J. Hoercher, A. Vahanian, R. O. Bonow, and W. O'Neill
Percutaneous and Minimally Invasive Valve Procedures: A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group
Circulation, April 1, 2008; 117(13): 1750 - 1767.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Feldman and M. B. Leon
Prospects for Percutaneous Valve Therapies
Circulation, December 11, 2007; 116(24): 2866 - 2877.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. J. Antunes
Off-pump aortic valve replacement with catheter-mounted valved stents.: Is the future already here?
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 1 - 3.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Percutaneous Treatment of Valvular Heart Disease
Journal Watch Cardiology, March 23, 2006; 2006(323): 3 - 3.
[Full Text]